ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $750,000 | +118.7% | 26,000 | +141.1% | 0.42% | +23.1% |
| Q3 2016 | $343,000 | -57.8% | 10,785 | -56.9% | 0.34% | -68.0% |
| Q2 2016 | $812,000 | +30.1% | 25,000 | +42.9% | 1.07% | +176.7% |
| Q4 2015 | $624,000 | -40.4% | 17,500 | -30.0% | 0.39% | -40.7% |
| Q2 2015 | $1,047,000 | +36.7% | 25,000 | +6.4% | 0.65% | +27.4% |
| Q1 2015 | $766,000 | -41.2% | 23,500 | -42.7% | 0.51% | -27.1% |
| Q4 2014 | $1,302,000 | +3.1% | 41,000 | -19.6% | 0.70% | -21.5% |
| Q3 2014 | $1,263,000 | -0.2% | 51,000 | -8.9% | 0.89% | +13.6% |
| Q2 2014 | $1,265,000 | -24.1% | 56,000 | -18.2% | 0.79% | -12.7% |
| Q1 2014 | $1,667,000 | -11.0% | 68,500 | -8.7% | 0.90% | -0.6% |
| Q4 2013 | $1,874,000 | -24.2% | 75,000 | -16.7% | 0.90% | -40.1% |
| Q3 2013 | $2,473,000 | +51.3% | 90,000 | 0.0% | 1.51% | +30.2% |
| Q2 2013 | $1,634,000 | – | 90,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |